Healthcare
Live Price
Offline$0.0001
+0.00% today
1Y Change
-99.33%
Window
Jun 23, 2025 → Jun 16, 2026
Coverage: 244 bars · Jun 23, 2025 → Jun 16, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
StateHouse Holdings Inc. (STHZF) is a Healthcare stock with a market cap of $10.00M and listed on OTC. The stock last traded around $0.00 and down 99.3% across the available one-year price window (Jun 23, 2025 → Jun 16, 2026). Baseline metrics include revenue growth of -5.4%, EPS growth of +81.7%, a dividend yield of 0.0%. What stands out right now is revenue -5.4%, EPS +81.7%, free cash flow +82.8% with operating margin -29.5% and ROIC 406.6%. Valuation is more restrained than many high-expectation growth names at price/sales 0.1. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines STHZF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
STHZF
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
STHZF Max Drawdown
-99.93%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for STHZF and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$47.3M
-25.0% YoY
FY Net Income
-$49.5M
-314.0% YoY
Free Cash Flow
-$12.7M
-407.4% YoY
Revenue Growth
-5.4%
EPS Growth
+81.7%
Gross Margin
45.1%
Net Margin
-49.6%
Income statement
USD
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 102M | 108M | 60M | 63M | 47M |
| Gross Profit | 43M | 43M | 22M | 30M | 15M |
| Operating Income | -30M | -6M | -42M | -4M | -18M |
| EBITDA | -3M | -2M | -846K | 5M | -14M |
| Net Income | -50M | -233M | -26M | -12M | -49M |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Cash & Equivalents | 2M | 3M | 9M | 10M | 12M |
| Total Assets | 123M | 166M | 154M | 115M | 115M |
| Total Liabilities | 285M | 277M | 106M | 96M | 90M |
| Shareholder Equity | -162M | -114M | 45M | 16M | 25M |
| Total Debt | 143M | 144M | 18M | 18M | 19M |
| Net Debt | 140M | 141M | 9M | 7M | 7M |
Cash flow positioning
Latest Full Year
Operating Cash Flow
9M
-430.4% YoY
Capital Expenditures
3M
-354.3% YoY
Free Cash Flow
13M
-407.4% YoY
Key ratios
Gross Margin
45.1%
Operating Margin
-29.5%
Net Margin
-49.6%
ROE
36.1%
Debt / Equity
-0.88x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.